Kathleen F Walsh, MD

Highlights

38

6 grants

Co-I
Determinants of TB Control, Relapse, and Reinfection
National Institute of Allergy and Infectious Diseases · 2026–2031
P01AI202868-06
PI
Sentinel populations and transmission hotspots of isoniazid-resistant tuberculosis
National Institute of Allergy and Infectious Diseases · 2023–2028Career
K23AI175686-04
KP
Tri-Institutional Tuberculosis Research Advancement Center
National Institute of Allergy and Infectious Diseases · 2022–2027
P30AI168433-01
KP
Tuberculosis Trials Consortium (TBTC) Clinical Research Services
Centers for Disease Control and Prevention · 2021–2026
75D30121C10170
Co-I
GHESKIO HIV Clinical Trial Unit (CTU)
National Institute of Allergy and Infectious Diseases · 2020–2026 · via GHESKIO Centers
UM1AI069421-15
Co-I
Determinants of TB control, relapse and reinfection
National Institute of Allergy and Infectious Diseases · 2021–2026
U19AI162568-01

Completed grants (3)

PI
Epidemiology of isoniazid-resistant tuberculosis
The Lura Cook Hull Trust · 2021–2022
LCHT 220430-01
Co-I
GHESKIO HIV Clinical Trial Unit (CTU)
National Institute of Allergy and Infectious Diseases · 2007–2020 · via GHESKIO Centers
U01AI069421-01
KP
VUMC 55755: Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (Walsh)
Fogarty International Center · 2015–2016 · via Vanderbilt University
R25TW009337-05

2

2 studies

PI
Social Behaviors of Adolescents and Adults with Pulmonary Tuberculosis to Inform Contact Tracing
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
PI
Isoniazid-resistant tuberculosis in Haiti
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)

Jumpstart Awards Recognize Early-Career Investigators
August 5, 2022
Six Weill Cornell Medicine postdoctoral associates, instructors and junior faculty seeking to pursue independent research careers have received 2022 JumpStart Career Development awards.